Get startedLog in
    Picture of Formosa Pharmaceuticals logo

    6838 — Formosa Pharmaceuticals Cashflow Statement

    0.000.00%
    tw flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Formosa Pharmaceuticals, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-220-398-402-300-180
    Depreciation
    Amortisation
    Non-Cash Items8.2939.43.128.830.4
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital0.038-9.8713.634.7-21.8
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-176-331-346-196-129
    Capital Expenditures-4.66-15.10-2.25-8.25
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.01-71-189-674-467
    Acquisition of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-4.67-86.1-189-676-475
    Financing Cash Flow Items——58.40—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities1586055591,000624
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-35.416758.411741.1